GlobalLink XCompare for eCOA

Reduce eCOA migration errors with XCompare technology that automates your development and migration workflows. 

Schedule a Demo
COA Migration

Avoid eCOA Migration Errors Before They Delay Your Research

As life sciences companies move away from administration of traditional COAs and toward electronic processes, TransPerfect’s GlobalLink XCompare™ technology straightens the path for eCOA adaptation and COA migration. Streamline your COA migration and mitigate risk with eCOA automation. Our proprietary solution makes ensuring accuracy and compliance of eCOA content easier and faster for your clinical team.

Improve Productivity and Compliance with GlobalLink XCompare™

XCompare’s automated development and translation workflows help clinical teams accelerate COA migrations, while vastly reducing errors, and follow global regulatory compliance. 

  • Control eCOA language quality during development
  • Guarantee accuracy of translated eCOA content for adapted and existing text
  • Export fully auditable and controlled reports
  • Use any file type
  • Reduce project delays
  • Reduce rounds of screenshot reviews

Manual Migration vs. XCompare Technology

Human-Led Migration

✘ Traditional migration methods include several lengthy manual processes, including manual copy/paste and manual reviews, which are prone to error.

XCompare Technology

✓ GlobalLink XCompare automates manual migration processes, reduces errors by 97%, and speeds up eCOA migration timelines by 50%.

Manual Source Key Creation

Create a manual source key to identify all the similarities and differences between pen/paper to the electronic version

Automated Migration

GlobalLink XCompare uses artificial intelligence (AI) to detect changes between paper and electronic versions and present them in a user-friendly report.

Manual Migration Process

Copy and paste the text manually into an electronic format while trying to implement adaptations.

Subject matter experts are required to do a manual review of every word, making it hard to identify slight deviations.

Automatic Track Changes

All changes are tracked in a comprehensive log for easy scanning, review, error identification, and decision-making.

Manual Quality Control

Relies on tedious, error-prone manual quality control checks across multiple versions of your documents and source key.

Consistent and Objective Quality Control

GlobalLink XCompare detects changes between the proposed target content and the approved paper versions, automatically flagging errors in the electronic translation when no discrepancies are present in the electronic source

Trusted by Life Sciences Organizations Big and Small

Join TransPerfect's community of more than 1,000 life sciences organizations, including pharma, biotech, CROs, IRBs, and agencies.

Biogen
Evidera/PPD
BMS
AstraZeneca

eCOA Migration Support by the Numbers


97 %

Reduction in migration errors

50 %

Reduction in review rounds

2.5 x

Decrease in screenshot compare time

GlobalLink logo no background

GlobalLink is the world’s most flexible translation management system. Since its introduction in 1999, TransPerfect’s GlobalLink translation management technology has helped many of the world’s leading life sciences organizations simplify the process of creating, releasing, and managing multilingual content.

News and Thought Leadership

Our industry experts have in-depth understanding of the challenges, requirements, and goals for life sciences organizations involved in clinical trial management.

Clinical Evidence in Digital Health: Considerations for Multi-Country Evidence Generation

The global adoption of digital health solutions has revolutionized healthcare delivery, offering unprecedented opportunities for innovation in patient care, diagnostics, and disease management. However, the generation of robust clinical evidence to support these technologies across diverse regulatory, cultural, and healthcare system contexts remains a significant challenge. In this webinar, Alexandra Crane, VP of COA, Digital Health, and Regulatory Solutions at ...

Clinical Evidence in Digital Health: Considerations for Multi-Country Evidence Generation

Sanofi’s Journey of Digital Transformation through AI-Powered Translations

The global clinical landscape is becoming more complex every day, with evolving regulations and increased pressure on life sciences organizations to reduce costs and timelines. Join us for an in-depth discussion on how one of the world’s leading pharma companies is leveraging AI ...

Lessons Learned from SCMS Deployments in Global Medical Device Documentation

Transitioning to modular content using a Structured Content Management System (SCMS) has the potential to transform medical device documentation by streamlining authoring and automating content updates and publishing. For a truly successful implementation, however, early planning ...

LifeSci Talks | Measuring What Matters: Modernizing Clinical Outcome Assessments with Patient-Centric Approaches

In this episode of LifeSci Talks, TransPerfect’s Global Practice Leader Mark Wade sits down with Dr. Karl McEvoy, VP of eCOA and Patient Technology at YPrime, to discuss the importance of embracing technology in clinical research to reduce the patient burden. The two cover ...

7 Essential Steps to Reach Global Audiences with Website Localization Services for Life Sciences Organizations

Website Localization for Life Sciences Organizations Means Greater Global ReachLife sciences organizations are under increasing pressure to connect with global audiences. With 65% of internet users preferring websites in their native language and 40% refusing to buy from...

Harnessing AI in Pharmacovigilance: Insights from World Drug Safety Amsterdam 2024

Pharmacovigilance professionals face an escalating challenge: data overload. From AI-powered transcription and case triage to automated literature translation, insights from the World Drug Safety Congress 2024 showcased practical solutions for streamlining workflows and reducing ...

Harnessing AI in Pharmacovigilance: Insights from World Drug Safety Amsterdam 2024

IntroductionIn the pharmacovigilance space, the overwhelming trend in the current landscape is data overload. Increasingly unmanageable volumes of information pose a core challenge for today’s pharmacovigilance professionals. While digital transformation and new technologies...

Ready to improve migration speed and quality?